Alveolar soft part sarcoma 'revisited': Clinicopathological review of 47 cases from a tertiary cancer referral centre, including immunohistochemical expression of TFE3 in 22 cases and 21 other tumours

Pathology

Volumn 44, Issue 1, 2012, Pages 11-17

  Rekhi, Bharat ^a   Ingle, Abhijeet ^a   Agarwal, Manish ^b   Puri, Ajay ^a   Laskar, Siddharth ^a   Jambhekar, Nirmala A ^a  

^a TATA MEMORIAL HOSPITAL   (India)

^b P D HINDUJA NATIONAL HOSPITAL   (India)

Author keywords

Alveolar soft part sarcoma; Immunohistochemistry of sarcomas; New sarcoma markers; Soft tissue tumours; TFE3; Uncommon sarcomas

Indexed keywords

EID: 84858260372     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0b013e32834d7ba4     Document Type: Article

References (45)

1. Christopherson WM, Foote FW Jr, Stewart FW. Alveolar soft-part sarcomas; structurally characteristic tumours of uncertain histogenesis. Cancer 1952; 5: 100-11.
2. Enzinger FM, Weiss SW. Malignant tumours of uncertain type. In: Enzinger FM, Weiss SW, editors. Soft Tissue Tumours. St Louis: Mosby, 1995; 1067-74.
3. Bu X, Bernstein L. A proposed explanation for female predominance in alveolar soft part sarcoma. Noninactivation of X; autosome translocation fusion gene? Cancer 2005; 103: 1245-53. (Pubitemid 40328096)
4. Dinshaw KA, Ganesh B. Hospital Based Cancer Registry. Annual Report 2002-2005, Tata Memorial Hospital, Mumbai, India. Mumbai: Tata Memorial Hospital, 2005; 1-110.
5. Lieberman PH, Brennan MF, Kimmel M, Erlandson RA, Garin-Chesa P, Flehinger BY. Alveolar soft-part sarcoma. A clinico-pathologic study of half a century. Cancer 1989; 63: 1-13. (Pubitemid 19031974)
6. Portera CA Jr, Ho V, Patel SR, et al. Alveolar soft part sarcoma: Clinical course and patterns of metastasis in 70 patients treated at a single institution. Cancer 2001; 91: 585-91. (Pubitemid 32105705)
7. Ogose A, Yazawa Y, Ueda T, et al. Japanese Musculoskeletal Oncology GroupAlveolar soft part sarcoma in Japan: Multi-institutional study of 57 patients from the Japanese Musculoskeletal Oncology Group. Oncology 2003; 65: 7-13. (Pubitemid 36829085)
8. Weiss SW. Alveolar soft part sarcoma. Are we at the end or just the beginning of our quest? (Commentary.) Am J Pathol 2002; 160: 1197-9.
9. Folpe AL, Deyrup AT. Alveolar soft-part sarcoma: A review and update. J Clin Pathol 2006; 59: 1127-32. (Pubitemid 44787132)
10. Rosai J, Dias P, Parham DM, Shapiro DN, Houghton P. MyoD1 protein expression in alveolar soft part sarcoma as confirmatory evidence of its skeletal muscle nature. Am J Surg Pathol 1991; 15: 974-81.
11. Foschini MP, Eusebi V. Alveolar soft-part sarcoma: A new type of rhabdomyosarcoma? Semin Diagn Pathol 1994; 11: 58-68. (Pubitemid 24092136)
12. Wang NP, Bacchi CE, Jiang JJ, McNutt MA, Gown AM. Does alveolar soft-part sarcoma exhibit skeletal muscle differentiation? An immunocytochemical and biochemical study of myogenic regulatory protein expression. Mod Pathol 1996; 9: 496-506. (Pubitemid 26170424)
13. Gómez JA, Amin MB, Ro JY, Linden MD, Lee MW, Zarbo RJ. Immunohistochemical profile of myogenin and MyoD1 does not support skeletal muscle lineage in alveolar soft part sarcoma. Arch Pathol Lab Med 1999; 123: 503-7. (Pubitemid 29255027)
14. Stockwin LH, Vistica DT, Kenney S, et al. Gene expression profiling of alveolar soft-part sarcoma (ASPS). BMC Cancer 2009; 9: 22.
15. Ladanyi M, Antonescu CR, Drobnjak M, et al. The precrystalline cytoplasmic granules of alveolar soft part sarcoma contain monocarboxylate transporter 1 and CD147. Am J Pathol 2002; 160: 1215-21. (Pubitemid 34411625)
16. Ladanyi M, Lui MY, Antonescu CR, et al. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene 2001; 20: 48-57. (Pubitemid 32142337)
17. Pang LJ, Chang B, Zou H, et al. Alveolar soft part sarcoma: A biomarker diagnostic strategy using TFE3 immunoassay and ASPL-TFE3 fusion transcripts in paraffin-embedded tumour tissues. Diagn Mol Pathol 2008; 17: 245-52.
18. Argani P, Lal P, Hutchinson B, Lui MY, Reuter VE, Ladanyi M. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: A sensitive and specific immunohistochemical assay. Am J Surg Pathol 2003; 27: 750-61. (Pubitemid 36617511)
19. Williams A, Bartle G, Sumathi VP, et al. Detection of ASPL/TFE3 fusion transcripts and the TFE3 antigen in formalin-fixed, paraffin-embedded tissue in a series of 18 cases of alveolar soft part sarcoma: Useful diagnostic tools in cases with unusual histological features. Virchows Arch 2011; 458: 291-300.
20. Fanburg-Smith JC, Miettinen M, Folpe AL, Weiss SW, Childers EL. Lingual alveolar soft part sarcoma; 14 cases: Novel clinical and morphological observations. Histopathology 2004; 45: 526-37. (Pubitemid 39524328)
21. Auerbach HE, Brooks JJ. Alveolar soft part sarcoma. A clinicopathologic and immunohistochemical study. Cancer 1987; 60: 66-73. (Pubitemid 17083552)
22. Jong R, Kandel R, Fornasier V, Bell R, Bedard Y. Alveolar soft part sarcoma: Review of nine cases including two cases with unusual histology. Histopathology 1998; 32: 63-8.
23. Ordonez NG, Mackay B. Alveolar soft-part sarcoma: A review of the pathology and histogenesis. Ultrastruct Pathol 1998; 22: 275-92. (Pubitemid 28485558)
24. Evans HL. Alveolar soft-part sarcoma. A study of 13 typical examples and one with a histologically atypical component. Cancer 1985; 55: 912-7. (Pubitemid 15173534)
25. Zucker S, Hymowitz M, Rollo EE, et al. Tumourigenic potential of extracellular matrix metalloproteinase inducer. Am J Pathol 2001; 158: 1921-8. (Pubitemid 32545174)
26. Avery AK, Beckstead J, Renshaw AA, Corless CL. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am J Surg Pathol 2000; 24: 203-10. (Pubitemid 30078709)
27. Mukai M, Torikata C, Shimoda T, Iri H. Alveolar soft part sarcoma. Assessment of immunohistochemical demonstration of desmin using paraffin sections and frozen sections. Virchows Arch A Pathol Anat Histopathol 1989; 414: 503-9. (Pubitemid 19148288)
28. Sciot R, Dal Cin P, De Vos R, et al. Alveolar soft-part sarcoma: Evidence for its myogenic origin and for the involvement of 17q25. Histopathology 1993; 23: 439-44. (Pubitemid 23355981)
29. Kirk P, Wilson MC, Heddle C, Brown MH, Barclay AN, Halestrap AP. CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression. EMBO J 2000; 19: 3896-904. (Pubitemid 30608530)
30. Daigeler A, Kuhnen C, Hauser J, et al. Alveolar soft part sarcoma: Clinicopathological findings in a series of 11 cases. World J Surg Oncol 2008; 6: 71.
31. Rekhi B, Jambhekar NA. Morphologic spectrum, immunohistochemical analysis, and clinical features of a series of granular cell tumours of soft tissues: A study from a tertiary referral cancer center. Ann Diagn Pathol 2010; 14: 162-7.
32. Ekfors TO, Kalimo H, Rantakokko V, Latvala M, Parvinen M. Alveolar soft part sarcoma: A report of two cases with some histochemical and ultrastructural observations. Cancer 1979; 43: 1672-7. (Pubitemid 9203715)
33. Ordonez N, Ladyani M. Alveolar soft part sarcoma. In: Fletcher CDM, Unni KK, Mertens F, et al., editors. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon: IARC Press, 2002.
34. Smetana HF, Scott WF Jr. Malignant tumours of nonchromaffin paraganglia. Mil Surg 1951; 109: 330-49.
35. Mukai M, Iri H, Nakajima T, et al. Alveolar soft-part sarcoma. A review on its histogenesis and further studies based on electron microscopy, immunohistochemistry, and biochemistry. Am J Surg Pathol 1983; 7: 679-89. (Pubitemid 14230813)
36. Kuiper RP, Schepens M, Thijssen J, Schoenmakers EF, van Kessel AG. Regulation of the MiTF/TFE bHLH-LZ transcription factors through restricted spatial expression and alternative splicing of functional domains. Nucleic Acids Res 2004; 32: 2315-22. (Pubitemid 38854786)
37. Weterman MAJ, van Groningen JJM, Jansen A, van Kessel AG. Nuclear localization and transactivating capacities of the papillary renal cell carcinoma-associated TFE3 and PRCC (fusion) proteins. Oncogene 2000; 19: 69-74. (Pubitemid 30066352)
38. Sidhar SK, Clark J, Gill S, et al. The t(X; 1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene. Hum Mol Genet 1996; 5: 1333-8. (Pubitemid 26335852)
39. Weterman MAJ, Wilbrink M, Janssen I, et al. Fusion of the transcription factor TFE3 gene to a novel gene, PRCC, in t(X;1)(p11;q21)- positive papillary renal cell carcinomas. Proc Natl Acad Sci USA 1996; 93: 15294-8.
40. Argani P, Antonescu CR, Illei PB, et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: A distinctive tumour entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol 2001; 159: 179-92. (Pubitemid 33704203)
41. Vistica DT, Krosky PM, Kenney S, Raffeld M, Shoemaker RH. Immunohistochemical discrimination between the ASPL-TFE3 fusion proteins of alveolar soft part sarcoma. J Pediatr Hematol Oncol 2008; 30: 46-52.
42. Rekhi B, Kumar R, Menon S, Medhi S, Desai SB. Calvarial metastasis of a renal cell carcinoma, mimicking a primary alveolar soft part sarcoma, in a young girl-a rare case report. Pathol Oncol Res 2009; 15: 137-41.
43. Camp RL, Charette LA, Rimm DL. Validation of tissue microarray technology in breast carcinoma. Lab Invest 2000; 80: 1943-9. (Pubitemid 32012762)
44. Kayton ML, Meyers P, Wexler LH, Gerald WL, La Quaglia MP. Clinical presentation, treatment, and outcome of alveolar soft part sarcoma in children, adolescents, and young adults. J Pediatr Surg 2006; 41: 187-93. (Pubitemid 43067515)
45. Casanova M, Ferrari A, Bisogno G, et al. Alveolar soft part sarcoma in children and adolescents: A report from the Soft-Tissue Sarcoma Italian Cooperative Group. Ann Oncol 2000; 11: 1445-9.